Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi-Targets: An Unconventional Drug Development Strategy for Alzheimer’s Disease
Cheng‐Xin Gong, Chun‐Ling Dai, Fei Liu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses
Mohammad Nasb, Weichu Tao, Ning Chen
Aging and Disease (2023)
Open Access | Times Cited: 50
Quinones as Neuroprotective Agents
Ángel Cores, Noelia Carmona-Zafra, José Clerigué, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1464-1464
Open Access | Times Cited: 42
Anti-Amyloid Therapies for Alzheimer’s Disease and the Amyloid Cascade Hypothesis
Ernesto Fedele
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14499-14499
Open Access | Times Cited: 31
N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer’s disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk
Dan Cheng, Zhuogui Lei, Kin Chu, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 12
Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History
Félix Bermejo‐Pareja, Teodoro del Ser
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 536-536
Open Access | Times Cited: 9
Targeting epigenetics: A novel promise for Alzheimer’s disease treatment
Danko Jeremic, Lydia Jiménez‐Díaz, Juan D. Navarro‐López
Ageing Research Reviews (2023) Vol. 90, pp. 102003-102003
Closed Access | Times Cited: 15
Discovery of triazole-bridged aryl adamantane analogs as an intriguing class of multifunctional agents for treatment of Alzheimer's disease
Gopichand Gutti, Jennifer Leifeld, Kakarla Ramakrishna, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115670-115670
Closed Access | Times Cited: 15
Seaweeds as Nutraceutical Elements and Drugs for Diabetes Mellitus: Future Perspectives
João Cotas, Silvia Lomartire, Leonel Pereira, et al.
Marine Drugs (2024) Vol. 22, Iss. 4, pp. 168-168
Open Access | Times Cited: 5
Co‐Assembled Nanoparticles toward Multi‐Target Combinational Therapy of Alzheimer's Disease by Making Full Use of Molecular Recognition and Self‐Assembly
Wen‐Bo Li, Linlin Xu, Si‐Lei Wang, et al.
Advanced Materials (2024) Vol. 36, Iss. 28
Closed Access | Times Cited: 5
In Vitro and In Vivo Investigations of Chromone Derivatives as Potential Multitarget-Directed Ligands: Cognitive Amelioration Utilizing a Scopolamine-Induced Zebrafish Model
Naveen Kumar, Kailash Jangid, Vishal Kumar, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 14, pp. 2565-2585
Closed Access | Times Cited: 5
Dietary supplementation and the role of phytochemicals against the Alzheimer's disease: Focus on polyphenolic compounds
Rayees Ahmad Naik, Roshni Rajpoot, Raj Kumar Koiri, et al.
The Journal of Prevention of Alzheimer s Disease (2025) Vol. 12, Iss. 1, pp. 100004-100004
Open Access
Multi‐Targeting Phytochemicals for Alzheimer's Disease
R. Bhattacharya, Raghuraj Singh, Archna Panghal, et al.
Phytotherapy Research (2025)
Open Access
Discovery of Effective Inhibitors Against Phosphodiesterase 9, a Potential Therapeutic Target of Alzheimer’s Disease with Antioxidant Capacities
Qian Zhou, Xu-Nian Wu, Weihao Luo, et al.
Antioxidants (2025) Vol. 14, Iss. 2, pp. 123-123
Open Access
Specific Rosetta-based protein-peptide prediction protocol allows the design of novel cholinesterase inhibitor peptides
Iván Sanchis, Florencia Aimaretti, Matias Lupotti, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108202-108202
Closed Access
Synthesis and biological evaluation of natural cleistanolate, its enantiomer and analogues
Jelena Kesić, Mirjana Popsavin, Goran Benedeković, et al.
European Journal of Medicinal Chemistry (2025), pp. 117326-117326
Closed Access
<i>N<sup>5</sup></i>-((perfluorophenyl)amino)glutamine regulates BACE1, tau phosphorylation, synaptic function, and neuroinflammation in Alzheimer's disease models
Junsik Kim, Y. Cho, Jeongmi Lee, et al.
BioScience Trends (2025) Vol. 19, Iss. 1, pp. 102-115
Open Access
Therapeutic Inhalation of Hydrogen Gas for Alzheimer’s Disease Patients and Subsequent Long-Term Follow-Up as a Disease-Modifying Treatment: An Open Label Pilot Study
Hirohisa Ono, Yoji Nishijima, Shigeo Ohta
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 434-434
Open Access | Times Cited: 13
Transcriptomic analysis of glutamate-induced HT22 neurotoxicity as a model for screening anti-Alzheimer’s drugs
Anchalee Prasansuklab, Suporn Sukjamnong, Atsadang Theerasri, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Precision medicine for psychosis: a revolution at the interface of psychiatry and neurology
Matcheri S. Keshavan, Brett A. Clementz
Nature Reviews Neurology (2023)
Closed Access | Times Cited: 12
Hippocampal delivery of neurotrophic factor-α1/carboxypeptidase E gene prevents neurodegeneration, amyloidosis, memory loss in Alzheimer’s Disease male mice
Lan Xiao, Xuyu Yang, Vinay Sharma, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 8, pp. 3332-3342
Open Access | Times Cited: 12
Navigating the GSK-3β inhibitors as versatile multi-target drug ligands in Alzheimer’s disease intervention – A comprehensive review
Nachiket Jitendra Joshi, Rajasekhar Reddy Alavala
Results in Chemistry (2024) Vol. 7, pp. 101500-101500
Open Access | Times Cited: 3
Microorganism-Derived Molecules as Enzyme Inhibitors to Target Alzheimer’s Diseases Pathways
Thi Hanh Nguyen, San‐Lang Wang, Van Bon Nguyen
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 580-580
Open Access | Times Cited: 8
Multifunctional effect of flavonoids from Millettia brandisiana against Alzheimer's disease pathogenesis
Puguh Novi Arsito, Pornthip Waiwut, Chavi Yenjai, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21894-e21894
Open Access | Times Cited: 8
Agents at the Peak of US FDA Approval for the Treatment of Alzheimer’s Disease
Jahangir Alam, Anushka Kalash, Md. Imtaiyaz Hassan, et al.
Neurological Research (2024) Vol. 46, Iss. 4, pp. 318-325
Closed Access | Times Cited: 2
Mannich Reaction Mediated Derivatization of Chromones and Their Biological Evaluations as Putative Multipotent Ligands for the Treatment of Alzheimer’s Disease
Naveen Kumar, Kailash Jangid, Vinay Kumar, et al.
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top